AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7502
+0.0002 (0.03%)
At close: Jun 2, 2026, 4:00 PM EDT
0.7502
0.00 (0.00%)
Pre-market: Jun 3, 2026, 4:00 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $19.74 million as of June 2, 2026. Its market cap has increased by 249.14% in one year.
Market Cap
19.74M
Enterprise Value
15.86M
1-Year Change
249.14%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $19.74M, a decrease of -69.00%. That is a compound annual growth rate of -20.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 19.74M | 51.55% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 22.55M |
| Traws Pharma | 22.27M |
| CEL-SCI | 21.45M |
| Exicure | 21.23M |
| Curis | 20.93M |
| Tempest Therapeutics | 20.80M |
| Passage Bio | 18.77M |
| NewcelX | 18.74M |